Severe abuse of psychotropic drugs during pregnancy with good perinatal outcome. 1983

R Erkkola, and P Kero, and J Kanto, and L Aaltonen

A case of severe abuse of phenothiazines, benzodiazepines and barbiturates and smoking 40 cigarettes a day throughout pregnancy is described. Intoxication requiring hospitalization occurred 3 times during pregnancy. The mother was hospitalized for the last 10 days of pregnancy and only lorazepam and oxazepam were given in order to improve the co-operation of the mother and to alleviate fetal withdrawal symptoms. At 39 weeks a healthy baby boy of 3150 g was delivered. Obvious withdrawal symptoms in the neonate appeared at the age of 20 hours. Due to repeated drug intoxications of the mother after discharge, the baby was located in a custody home. At his postnatal examination at the age of 3 months the baby appeared somatically and neurologically unaffected. A slight muscular hypotonia of lower limbs was suspected, though. At check-ups at the age of 6 and 12 months the baby was normal in all respects.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001034 Apgar Score A method, developed by Dr. Virginia Apgar, to evaluate a newborn's adjustment to extrauterine life. Five items - heart rate, respiratory effort, muscle tone, reflex irritability, and color - are evaluated 60 seconds after birth and again five minutes later on a scale from 0-2, 0 being the lowest, 2 being normal. The five numbers are added for the Apgar score. A score of 0-3 represents severe distress, 4-7 indicates moderate distress, and a score of 7-10 predicts an absence of difficulty in adjusting to extrauterine life. Score, Apgar
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

R Erkkola, and P Kero, and J Kanto, and L Aaltonen
January 1996, L'Encephale,
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
September 1989, American journal of obstetrics and gynecology,
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
November 1996, Journal of clinical epidemiology,
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
January 2016, BMJ (Clinical research ed.),
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
February 2012, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina,
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
November 2000, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
December 1989, Obstetrics and gynecology,
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
February 2017, Shanghai archives of psychiatry,
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
January 1991, American journal of human biology : the official journal of the Human Biology Council,
R Erkkola, and P Kero, and J Kanto, and L Aaltonen
January 1999, Gynakologisch-geburtshilfliche Rundschau,
Copied contents to your clipboard!